Medscape is available in 5 Language Editions – Choose your Edition here.


Roseola Infantum in Emergency Medicine Medication

  • Author: Lisa S Lewis, MD; Chief Editor: Kirsten A Bechtel, MD  more...
Updated: Jan 15, 2015

Medication Summary

To date, no controlled antiviral trials exist against HHV-6. However, treatment is recommended with end-organ disease in the transplantation population. Anecdotal reports of ganciclovir suggest that it may be beneficial in these patients.[8]

Contributor Information and Disclosures

Lisa S Lewis, MD Attending Physician, Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center

Lisa S Lewis, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Grace M Young, MD Associate Professor, Department of Pediatrics, University of Maryland Medical Center

Grace M Young, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Emergency Physicians

Disclosure: Nothing to disclose.

Chief Editor

Kirsten A Bechtel, MD Associate Professor of Pediatrics, Section of Pediatric Emergency Medicine, Yale University School of Medicine; Co-Director, Injury Free Coalition for Kids, Yale-New Haven Children's Hospital

Kirsten A Bechtel, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Additional Contributors

Garry Wilkes, MBBS, FACEM Director of Clinical Training (Simulation), Fiona Stanley Hospital; Clinical Associate Professor, University of Western Australia; Adjunct Associate Professor, Edith Cowan University, Western Australia

Disclosure: Nothing to disclose.

  1. Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, Wald A. A population-based study of primary human herpesvirus 6 infection. N Engl J Med. 2005 Feb 24. 352(8):768-76. [Medline].

  2. Dockrell DH, Paya CV. Human herpesvirus-6 and -7 in transplantation. Rev Med Virol. 2001 Jan-Feb. 11(1):23-36. [Medline].

  3. Stoeckle M. The spectrum of human herpesvirus 6 infection: from roseola infantum to adult disease. Annu Rev Med. 2000. 51:423-430. [Medline].

  4. Vianna RA, de Oliveira SA, Camacho LA, Knowles W, Brown D, Pereira AC, et al. Role of human herpesvirus 6 infection in young Brazilian children with rash illnesses. Pediatr Infect Dis J. 2008 Jun. 27(6):533-7. [Medline].

  5. Tanaka-Taya K, Sashihara J, Kurahashi H, Amo K, Miyagawa H, Kondo K, et al. Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol. 2004 Jul. 73(3):465-73. [Medline].

  6. Boutolleau D, Duros C, Bonnafous P, Caiola D, Karras A, Castro ND, et al. Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. J Clin Virol. 2006 Mar. 35(3):257-63. [Medline].

  7. Huang CT, Lin LH. Differentiating roseola infantum with pyuria from urinary tract infection. Pediatr Int. 2013 Apr. 55(2):214-8. [Medline].

  8. Lautenschlager I, Razonable RR. Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review. Transpl Int. 2012 May. 25(5):493-502. [Medline].

  9. Yoshikawa T, Ohashi M, Miyake F, Fujita A, Usui C, Sugata K, et al. Exanthem subitum-associated encephalitis: nationwide survey in Japan. Pediatr Neurol. 2009 Nov. 41(5):353-8. [Medline].

  10. Yoshikawa T, Asano Y. Central nervous system complications in human herpesvirus-6 infection. Brain Dev. 2000 Aug. 22(5):307-14. [Medline].

  11. Dyer JA. Childhood viral exanthems. Pediatr Ann. 2007 Jan. 36(1):21-9. [Medline].

  12. Theodore WH, Epstein L, Gaillard WD, Shinnar S, Wainwright MS, Jacobson S. Human herpes virus 6B: a possible role in epilepsy?. Epilepsia. 2008 Nov. 49(11):1828-37. [Medline]. [Full Text].

  13. Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol. 2007 Nov. 157(5):934-40. [Medline].

  14. American Academy of Pediatrics. Human herpesvirus 6 (including roseola) and 7. Pickering, LK, ed. Red Book: Report of the Committee on Infectious Diseases. 2003. 357-359.

  15. Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T. Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics. 1994 Jan. 93(1):104-8. [Medline].

  16. Braun DK, Dominguez G, Pellett PE. Human herpesvirus 6. Clin Microbiol Rev. 1997 Jul. 10(3):521-67. [Medline].

  17. Campadelli-Fiume G, Mirandola P, Menotti L. Human herpesvirus 6: An emerging pathogen. Emerg Infect Dis. 1999 May-Jun. 5(3):353-66. [Medline]. [Full Text].

  18. Cherry JD. Contemporary infectious exanthems. Clin Infect Dis. 1993 Feb. 16(2):199-205. [Medline].

  19. De Araujo T, Berman B, Weinstein A. Human herpesviruses 6 and 7. Dermatol Clin. 2002 Apr. 20(2):301-6. [Medline].

  20. Dockrell DH. Human herpesvirus 6: molecular biology and clinical features. J Med Microbiol. 2003 Jan. 52(Pt 1):5-18. [Medline].

  21. Drago F, Rebora A. The new herpesviruses: emerging pathogens of dermatological interest. Arch Dermatol. 1999 Jan. 135(1):71-5. [Medline].

  22. Frieden IJ, Resnick SD. Childhood exanthems. Old and new. Pediatr Clin North Am. 1991 Aug. 38(4):859-87. [Medline].

  23. Grossman KL, Rasmussen JE. Recent advances in pediatric infectious diseases and their impact on dermatology. J Am Acad Dermatol. 1991 Mar. 24(3):379-89. [Medline].

  24. Hukin J, Farrell K, MacWilliam LM, Colbourne M, Waida E, Tan R. Case-control study of primary human herpesvirus 6 infection in children with febrile seizures. Pediatrics. 1998 Feb. 101(2):E3. [Medline].

  25. Hurwitz S. Clinical Pediatric Dermatology. 2nd ed. WB Saunders Co; 1993. 35.

  26. Jones CA, Isaacs D. Human herpesvirus-6 infections. Arch Dis Child. 1996 Feb. 74(2):98-100. [Medline].

  27. Leach CT. Human herpesvirus-6 and -7 infections in children: agents of roseola and other syndromes. Curr Opin Pediatr. 2000 Jun. 12(3):269-74. [Medline].

  28. Millichap JG, Millichap JJ. Role of viral infections in the etiology of febrile seizures. Pediatr Neurol. 2006 Sep. 35(3):165-72. [Medline].

  29. Okada K, Ueda K, Kusuhara K, Miyazaki C, Tokugawa K, Hirose M. Exanthema subitum and human herpesvirus 6 infection: clinical observations in fifty-seven cases. Pediatr Infect Dis J. 1993 Mar. 12(3):204-8. [Medline].

  30. Prober C. Sixth disease and the ubiquity of human herpesviruses. N Engl J Med. 2005 Feb 24. 352(8):753-5. [Medline].

  31. Ranger S, Patillaud S, Denis F, Himmich A, Sangare A, M'Boup S. Seroepidemiology of human herpesvirus-6 in pregnant women from different parts of the world. J Med Virol. 1991 Jul. 34(3):194-8. [Medline].

  32. Scott LA, Stone MS. Viral exanthems. Dermatol Online J. 2003 Aug. 9(3):4. [Medline].

  33. Suga S, Yoshikawa T, Asano Y, Yazaki T, Hirata S. Human herpesvirus-6 infection (exanthem subitum) without rash. Pediatrics. 1989 Jun. 83(6):1003-6. [Medline].

  34. Ward KN. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J Clin Virol. 2005 Mar. 32(3):183-93. [Medline].

  35. Ward KN, Andrews NJ, Verity CM, Miller E, Ross EM. Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child. 2005 Jun. 90(6):619-23. [Medline].

  36. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988 May 14. 1(8594):1065-7. [Medline].

Discrete rose-pink macules/maculopapules characteristic of roseola infantum.
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.